Barbara Taylor

Barbara Taylor supports the National Institutes of Health’s Clinical Center in procuring mission-critical scientific and diagnostic infrastructure essential to advancing biomedical research. She manages the acquisition of precision laboratory equipment, in-vitro diagnostic substances, bioanalytical software, and specialized technical services that enable cutting-edge disease research and therapeutic development. Her procurement activities directly support the agency’s strategic goal of expanding research capacity through the timely acquisition of high-accuracy instrumentation and validated analytical systems used in clinical and translational studies. Taylor maintains a consistent working relationship with Standard Calibrations Inc., a key vendor providing calibration, maintenance, and metrology services for sensitive laboratory equipment. Her contracting patterns reflect a preference for established technical service providers with proven expertise in scientific instrument lifecycle support, indicating a focus on reliability, compliance, and long-term operational integrity over transactional procurement. She engages vendors who demonstrate deep domain knowledge in regulatory standards such as ISO 17025 and CLIA compliance. Her contracting portfolio is overwhelmingly non-set-aside, with 97.8% of awards issued under full and open competition, reflecting a prioritization of technical capability and performance over socioeconomic preferences. While small business participation is minimal at 2.2%, it is consistently aligned with Total Small Business Set-Asides under FAR 19.5, suggesting targeted opportunities for qualified firms with niche technical expertise rather than broad socioeconomic mandates. Taylor’s procurement focus centers on NAICS 811219 (Other Commercial and Industrial Machinery and Equipment Repair), 325413 (In-Vitro Diagnostic Substance Manufacturing), and 325414 (Biological Product Manufacturing), indicating deep engagement with diagnostic reagents, calibrants, and biological standards. She routinely sources precision tools and software for clinical labs and bioanalytical workflows, demonstrating specialized expertise in the procurement of GMP-compliant, FDA-regulated research materials and instrumentation critical to NIH’s mission of accelerating medical innovation.